申请人:Bosmans Jean-Paul R.M.A.
                            
                            
                                公开号:US20100280025A1
                            
                            
                                公开(公告)日:2010-11-04
                            
                            The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENT1 inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENT1 receptors in animals, in particular humans.